# Sequential Combination Therapy in Bladder Cancer

> **NCT03790384** · PHASE4 · UNKNOWN · sponsor: **Azienda Ospedaliera "Sant'Andrea"** · enrollment: 140 (estimated)

## Conditions studied

- Bladder Cancer

## Interventions

- **DRUG:** Mitomycin

## Key facts

- **NCT ID:** NCT03790384
- **Lead sponsor:** Azienda Ospedaliera "Sant'Andrea"
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-01-15
- **Primary completion:** 2019-09-15
- **Final completion:** 2021-01-15
- **Target enrollment:** 140 (ESTIMATED)
- **Last updated:** 2018-12-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03790384

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03790384, "Sequential Combination Therapy in Bladder Cancer". Retrieved via AI Analytics 2026-07-05 from https://api.ai-analytics.org/clinical/NCT03790384. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*